See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.01▲ 0.54%
← 0A39 page
XStocksXray
Market X-Ray report · 22 October 2026

Karnov Group AB (0A39)

London Exchange · UK · prices in SEK · close of 22 Oct 2026

Key indicators

Last closeSEK 81.00
52-week range60.20 – 115.60
Return, 1 month / 3 months+8.0% / +15.7%
Return, 1 year / 3 years−22.3% / +77.3%
TrendUptrend
RSI (14)63
Volatility (1 year)44.6%
Worst drawdown (1 year)-46.7%
Average daily value traded1.54M SEK
Dividend yield–

Market X-Ray price-based

48/ 100 · High confidence · ahead of 42% of stocks on this exchange
Trend54
Momentum54
Stability (higher is calmer)29
Liquidity57
Income–

Five-year price chart navy: price · brown: 200-day average

34.8759.2683.651081322021-102023-012024-052025-082026-10

About the company

Karnov Group is a Swedish company that supplies legal, tax and regulatory information and software. It publishes online databases, commentaries and workflow tools that help lawyers, courts, public authorities and businesses find and apply legislation and case law. Its customers are mainly professionals in the Nordic countries and other European markets who rely on its reference material and digital services for legal research and compliance work. The company is based in Stockholm.

On this site Karnov Group AB appears as a stock on the London Exchange (UK), code 0A39, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Karnov Group AB (0A39) trades on the London Exchange in UK. It last closed at SEK 81.00 on 22 October 2026.

Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,198 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 22.3% and over the last three months it rose 15.7%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Karnov Group AB (0A39)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend54 · FairMixed trend against its averages.
Above 200-day average7.5%
From 52-week high-28.7%
Momentum54 · FairTypical recent returns for this exchange.
3-month return15.7%
6-month return6.3%
12-month return, skipping the last month-28.0%
Stability (higher is calmer)29 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)44.6%
Worst drawdown, 1 year (smaller is calmer)-46.7%
Liquidity57 · FairModerate trading activity.
Average daily value traded1.54M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+2.7%
1 month+8.0%
3 months+15.7%
6 months+6.3%
1 year−22.3%
3 years+77.3%
5 years+40.6%

Signals

50-day / 200-day average77.54 / 75.33
Golden / death cross (60 days)Golden, 8 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.47

Technical summary

DailyStrongly bullish12 bullish · 2 neutral · 2 bearish
WeeklyStrongly bullish9 bullish · 1 neutral · 2 bearish
MonthlyNeutral3 bullish · 1 neutral · 4 bearish

Recent dividends

Ex-dividend dateAmount per share
6 May 2021SEK 1.0000
6 May 2020SEK 0.4500

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026